ThursdayMar 26, 2009 7:07 am

Nutra Pharma Corp. (NPHC.OB) Subsidiary Introduces Cost Effective Contract Research Services

Nutra Pharma Corp., a biotechnology company focused on developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), announced today that its wholly-owned drug discovery subsidiary, ReceptoPharm, has introduced a line of specialized contract research services targeted at the early-stage life science market. “As a clinical stage company specializing in biologics, we understand and have cleared many of the hurdles that face emerging biotech companies,” stated Dr. Paul Reid, CEO of ReceptoPharm. “This knowledge, combined with our qualified drug production facility, allows us to leverage our expertise and capabilities by extending them to small and start-up biotechnology companies looking for…

Continue Reading

ThursdayMar 26, 2009 7:03 am

New Generation Biofuels Holdings, Inc. (NGBF) Announces Sales Contract to Supply up to 370,000 gallons of Renewable Biofuel

New Generation Biofuels Holdings, Inc. announced today before the opening bell that it is has signed a sales contract with Catoctin Mountain Growers, Inc. of Keymar, Maryland to supply up to 370,000 gallons of renewable biofuel annually. “We are delighted to be supplying a proactive and environmentally aware company like Catoctin Mountain Growers with our biofuel, which provides a lower carbon footprint and is 100 percent renewable,” commented Cary Claiborne, CEO and CFO of New Generation Biofuels. “In a test completed on one of Catoctin's Cleaver-Brooks boilers, our biofuel demonstrated air pollution reductions of more than 45% in nitrogen oxides…

Continue Reading

WednesdayMar 25, 2009 1:19 pm

CityView Corporation Limited (CTVWF.OB) Forms Joint Venture with Deanshanger Project Ltd. to Acquire Nigerian-based Refinery

CityView Corporation Limited (CTVWF.OB) is an Australian-based natural resource company with a diverse portfolio of copper, gold, diamonds, coal, iron ore, rare earths and oil refinery interests. The company today announced a joint venture with Deanshanger Project Ltd. for the acquisition of a crude oil refinery with a daily capacity of 55,000 barrels. The acquired Tagore Investments S.A. refinery will later be revamped to produce 100,000 barrels each day, and will be relocated to Nigeria. CityView CEO Mark Smyth said the company will commence shipment and construction of the new refinery this year, and will begin operations in early 2010.…

Continue Reading

WednesdayMar 25, 2009 8:30 am

Axial Vector Energy Corp. (AXVC.PK) New Venture Cost Savings Impossible to Ignore

The Axial Vector Energy Corp. (AXVC.PK) Petrosonics joint venture offers the world’s oil processing industry a technology and cost savings that is sorely needed. Axial Vector’s earlier announcement that it has teamed up with Petrosonics to form a joint venture company named Petro-AVEC means that Petrosonics’ unique sulfur removal process will now have the backing to be marketed worldwide. Axial’s AVEC Acquisitions subsidiary is contributing nearly $7 million to the venture to help market and continue development of the technology. The innovative process uses high power ultrasound to reduce sulfur, nitrogen, and trace metals in oil. A side benefit is…

Continue Reading

WednesdayMar 25, 2009 6:09 am

ADVENTRX Pharmaceuticals, Inc. (ANX) Grants Exclusive Rights to Lead Product Candidate

ADVENTRX Pharmaceuticals, Inc. announced that it has granted Shin Poong Pharmaceutical Co., Ltd. (SEO: 019170.KS) the exclusive rights to make, use and sell ANX-514 (docetaxel emulsion), one of its two lead product candidates, in South Korea. In exchange, ADVENTRX will receive an upfront cash payment of $300,000, up to approx. $2 million in regulatory and commercial milestones, and royalties on net sales of licensed products. "Shin Poong is well-positioned to successfully develop and commercialize ANX-514 in South Korea," commented Brian M. Culley, Chief Business Officer of ADVENTRX. "Established in 1962, Shin Poong has grown to more than 1,500 employees. They…

Continue Reading

WednesdayMar 25, 2009 6:00 am

China 3C Group (CHCG.OB) Announces Financial Results for Fourth Quarter and Full Year 2008

China 3C Group, a retailer and wholesale distributor of consumer and business products in China, reported its financial results for the fourth quarter and full year of 2008. Net sales for the fourth quarter of 2008 totaled $84.9 million, a 22.9% increase compared to $69.1 million for the same period of the prior year. The company's retail business accounted for approximately 68% of sales while the wholesale business generated approximately 32% of sales. Net sales for last year increased 13% to $310.6 million, versus $276.0 million for 2007. General and administrative expenses for the year totaled $14.1 million, or approximately…

Continue Reading

WednesdayMar 25, 2009 5:49 am

Human Genome Sciences, Inc. (HGSI) and Morphotek(R), Inc. Partner Up to Discover, Develop and Commercialize Antibodies for Oncology and Immunology

Today, Human Genome Sciences, Inc. and Morphotek®, Inc., a subsidiary of Eisai Corporation of North America, announced together that they have entered into a collaboration to discover, develop and commercialize therapeutic monoclonal antibodies in the fields of oncology and immunology, specifically targeting antigens discovered by HGS. “The rapid commercialization of our late-stage compounds continues to be the priority focus of HGS. At the same time, we also remain committed to advancing our earlier and mid-stage programs in development to ensure sustainable growth well into the future,” stated H. Thomas Watkins, President and Chief Executive Officer, HGS. “We look forward to…

Continue Reading

WednesdayMar 25, 2009 5:24 am

YANGAROO Inc.’s (YOOIF.OB) DMDS 5.0 Saves Costs and Enables Green Initiative for Canada’s Juno Awards

YANGAROO Inc., a leading secure digital media distribution company, announced today that its Digital Media Distribution System (DMDS) successfully slashed costs and provided an environmentally-friendly method for distributing music and enabling the judging process for The Canadian Academy of Recording Arts and Sciences (CARAS) in association with this year’s JUNO Awards. Utilizing the technological capabilities of YANGAROO’s new DMDS 5.0 platform, more than 300 jury and 1,700 Academy members were able to review submitted materials online, eliminating the need to collect, manage and distribute approx. 15,000 physical CDs. The digital process also helped reduce costs and waste from packaging and…

Continue Reading

WednesdayMar 25, 2009 5:18 am

IntelGenx Technologies Corp. (IGXT.OB) Reports Financial Results for 2008

IntelGenx Technologies Corp., a drug delivery company dedicated to developing oral controlled-release products as well as novel rapidly disintegrating delivery systems, this morning announced financial results for the year ended December 31, 2008. "2008 was an exciting year for IntelGenx" commented Horst Zerbe, President and Chief Executive Officer of IntelGenx. "In the fourth quarter, the first product involving the company's proprietary "Versatab" technology, a prenatal vitamin combination was launched under the brand name Gesticare®. We also formed a strategic alliance with DAVA Pharmaceuticals Inc., and completed development of the CPI-300 anti-depressant. In addition, we completed an equity financing and received…

Continue Reading

TuesdayMar 24, 2009 11:22 am

BioNeutral Group, Inc. (BONU.OB) Enters LOI to Acquire Orient Arts

BioNeutral Group, Inc., a chemical technology-based Life Science company with novel combinational chemistry, announced today that it has signed a Letter of Intent (LOI) to acquire Orient Arts Inc., a manufacturer of fibers, textiles and finished goods. BioNeutral Group plans to acquire the company through an issuance of common shares. Orient Arts and its affiliated companies are focused on manufacturing, designing and producing finished goods in Asia, the world’s largest and most populous continent. Generating collective annual sales of more than $10 million, Orient Arts and its affiliate companies have licensing agreements in place with several celebrities. Stephen J. Browand,…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered